ArticlebioRxiv : the preprint server for biology2023
GSK-3 inhibitor elraglusib enhances tumor-infiltrating immune cell activation in tumor biopsies and synergizes with anti-PD-L1 in a murine model of colorectal cancer.
Kelsey E Huntington et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.